Potent and specific inhibition of human immunodeficiency virus type 1 replication by 4-(2,6-dichlorophenyl)-1,2,5-thiadiazol-3-Y1 N,N-dialkylcarbamate derivatives
K. Ijichi(NTT (Japan)), Katsuhiro Konno(University of Toyama), S. Shirakawa(NTT (Japan)), Masatoshi Fujiwara(NTT (Japan)), Kimio Katsuura(NTT (Japan)), Hiroshi Takayama(Shinshu University), Hiroyoshi Watanabe(Tokushima University), Yasuaki Hanasaki(NTT (Japan)), Shirô Shigeta(NTT (Japan)), Satoshi Sakai(University of Tsukuba)
Cited by 16
Related Papers
Factors associated with granulocyte colony‐stimulating factor‐induced peripheral blood stem cell yield in healthy donors
|Vox Sanguinis|2005|118
Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking
|Transfusion|2004|114
The first selective linear codimerization of terminal acetylenes and 1,3-dienes catalyzed by dihydridotetrakis(trialkylphosphine)ruthenium complexes
|The Journal of Organic Chemistry|1985|89
Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair
|Journal of Thoracic and Cardiovascular Surgery|1995|87
Synthetic Studies of Vitamin D Analogues. XIV. Synthesis and Calcium Regulating Activity of Vitamin D3 Analogues Bearing a Hydroxyalkoxy Group at the 2.BETA.-Position.
|Chemical and Pharmaceutical Bulletin|1993|82